Fortress Biotech (FBIO)
(Delayed Data from NSDQ)
$2.25 USD
-0.35 (-13.46%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $2.25 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
FBIO 2.25 -0.35(-13.46%)
Will FBIO be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for FBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FBIO
Here Is Why Bargain Hunters Would Love Fast-paced Mover Fortress Biotech (FBIO)
AquaBounty Technologies, Inc. (AQB) Reports Q1 Loss, Misses Revenue Estimates
FBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ovid Therapeutics (OVID) Reports Q1 Loss, Tops Revenue Estimates
Aveanna Healthcare (AVAH) Reports Q1 Loss, Tops Revenue Estimates
Myriad Genetics (MYGN) Reports Q2 Loss, Misses Revenue Estimates
Other News for FBIO
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Fortress Biotech reduces total debt, enters $35M term loan
Fortress Biotech Reduces Total Debt and Enters into New $35 Million Term Loan with Oaktree with Maturity in 2027
Fortress Biotech secures loan of up to $50M